These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37660472)

  • 1. The assessment of pathological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer patients with DCE-MRI and DWI: a systematic review and meta-analysis.
    Zong R; Ma X; Shi Y; Geng L
    Br J Radiol; 2023 Oct; 96(1150):20230239. PubMed ID: 37660472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic performance of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in evaluating the pathological response of breast cancer to neoadjuvant chemotherapy: A meta-analysis.
    Li Z; Li J; Lu X; Qu M; Tian J; Lei J
    Eur J Radiol; 2021 Oct; 143():109931. PubMed ID: 34492627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Quantitative Dynamic Contrast-Enhanced MRI for the Assessment of Neoadjuvant Chemotherapy in Breast Cancer.
    Jun W; Cong W; Xianxin X; Daqing J
    Am Surg; 2019 Jun; 85(6):645-653. PubMed ID: 31267907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of contrast-enhanced dynamic and diffusion-weighted MR imaging in the assessment of tumor response to neoadjuvant therapy in muscle-invasive bladder cancer.
    Ahmed SA; Taher MGA; Ali WA; Ebrahem MAES
    Abdom Radiol (NY); 2021 Jun; 46(6):2712-2721. PubMed ID: 33547919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    Tang S; Xiang C; Yang Q
    Br J Radiol; 2020 Aug; 93(1112):20200301. PubMed ID: 32574075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI.
    Woo S; Becker AS; Das JP; Ghafoor S; Arita Y; Benfante N; Gangai N; Teo MY; Goh AC; Vargas HA
    Cancer Imaging; 2023 Nov; 23(1):110. PubMed ID: 37964386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT.
    An YY; Kim SH; Kang BJ; Lee AW
    J Korean Med Sci; 2015 Jun; 30(6):808-15. PubMed ID: 26028936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review and meta-analysis of the accuracy of diffusion-weighted MRI in the detection of malignant pulmonary nodules and masses.
    Li B; Li Q; Chen C; Guan Y; Liu S
    Acad Radiol; 2014 Jan; 21(1):21-9. PubMed ID: 24331261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic performance of diffusion-weighted imaging combined with dynamic contrast-enhanced magnetic resonance imaging for prostate cancer: a systematic review and meta-analysis.
    Yang L; Tan Y; Dan H; Hu L; Zhang J
    Acta Radiol; 2021 Sep; 62(9):1238-1247. PubMed ID: 32903025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of pathological complete response after neoadjuvant systemic treatment of invasive breast cancer using diffusion-weighted imaging compared with dynamic contrast-enhanced based kinetic analysis.
    Ota R; Kataoka M; Iima M; Honda M; Ohashi A; Ohno Kishimoto A; Miyake KK; Yamada Y; Takeuchi Y; Toi M; Nakamoto Y
    Eur J Radiol; 2022 Sep; 154():110372. PubMed ID: 35667297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diagnostic Performance of DCE-MRI in Evaluating the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer: A Meta-Analysis.
    Cheng Q; Huang J; Liang J; Ma M; Ye K; Shi C; Luo L
    Front Oncol; 2020; 10():93. PubMed ID: 32117747
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy.
    Hahn SY; Ko EY; Han BK; Shin JH; Ko ES
    Eur J Radiol; 2014 Feb; 83(2):283-8. PubMed ID: 24315957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI for Assessing Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer Using DCE-MR and DW-MR Data Sets: A Preliminary Report.
    Petrillo M; Fusco R; Catalano O; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Petrillo A
    Biomed Res Int; 2015; 2015():514740. PubMed ID: 26413528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall diagnostic accuracy of different MR imaging sequences for detection of dysplastic nodules: a systematic review and meta-analysis.
    Xiong J; Luo J; Bian J; Wu J
    Eur Radiol; 2022 Feb; 32(2):1285-1296. PubMed ID: 34357448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of MRI in Predicting Early Response to Radiotherapy and Chemotherapy in Esophageal Cancer.
    Li X; Yuan F; Ni L; Li X
    Acad Radiol; 2024 Sep; ():. PubMed ID: 39266443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer.
    Li X; Abramson RG; Arlinghaus LR; Kang H; Chakravarthy AB; Abramson VG; Farley J; Mayer IA; Kelley MC; Meszoely IM; Means-Powell J; Grau AM; Sanders M; Yankeelov TE
    Invest Radiol; 2015 Apr; 50(4):195-204. PubMed ID: 25360603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis.
    Bi Q; Chen Y; Chen J; Zhang H; Lei Y; Yang J; Zhang Y; Bi G
    Clin Imaging; 2021 Oct; 78():206-213. PubMed ID: 34049140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.